SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jensen Gorm Boje)
 

Sökning: WFRF:(Jensen Gorm Boje) > (2019) > Circulating endosta...

  • Ruge, ToralphDepartment of Emergency Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden. (författare)

Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease : A CLARICOR trial sub-study

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2019
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-382572
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-382572URI
  • https://doi.org/10.1016/j.atherosclerosis.2019.02.031DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:du-29873URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:140892745URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND AND AIMS: Raised levels of serum endostatin, a biologically active fragment of collagen XVIII, have been observed in patients with ischemic heart disease but association with incident cardiovascular events in patients with stable coronary heart disease is uncertain.METHODS: The CLARICOR-trial is a randomized, placebo-controlled trial of stable coronary heart disease patients evaluating 14-day treatment with clarithromycin. The primary outcome was a composite of acute myocardial infarction, unstable angina pectoris, cerebrovascular disease or all-cause mortality. In the present sub-study using 10-year follow-up data, we investigated associations between serum endostatin at entry (randomization) and the composite outcome and its components during follow-up. The placebo group was used as discovery sample (1204 events, n = 1998) and the clarithromycin-treated group as replication sample (1220 events, n = 1979).RESULTS: In Cox regression models adjusting for cardiovascular risk factors, glomerular filtration rate, and current pharmacological treatment, higher serum endostatin was associated with an increased risk of the composite outcome in the discovery sample (hazard ratio per standard deviation increase 1.11, 95% CI 1.03-1.19, p = 0.004), but slightly weaker and not statistically significant in the replication sample (hazard ratio 1.06, 95% CI 1.00-1.14, p = 0.06). In contrast, strong and consistent associations were found between endostatin and cardiovascular and all-cause mortality in all multivariable models and sub-samples. Addition of endostatin to a model with established cardiovascular risk factors provided no substantial improvement of risk prediction (<1%).CONCLUSIONS: Raised levels of serum endostatin might be associated with cardiovascular events in patients with stable coronary heart disease. The clinical utility of endostatin measurements remains to be established.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Carlsson, Axel C.Karolinska Institutet,Uppsala universitet,Kardiovaskulär epidemiologi,Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden(Swepub:uu)axeca883 (författare)
  • Kjøller, ErikDepartment of Cardiology, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark. (författare)
  • Hilden, JørgenSection of Biostatistics, University of Copenhagen, Copenhagen, Denmark. (författare)
  • Kolmos, Hans JørnDepartment of Clinical Microbiology, Odense University Hospital, Denmark. (författare)
  • Sajadieh, AhmadCopenhagen University Hospital of Bispebjerg & Frederiksberg, Denmark. (författare)
  • Kastrup, JensRigshospitalet of Copenhagen University, Denmark. (författare)
  • Jensen, Gorm BojeCopenhagen University Hospital Hvidovre, Denmark. (författare)
  • Larsson, AndersUppsala universitet,Klinisk kemi(Swepub:uu)andlarss (författare)
  • Nowak, ChristophKarolinska Institutet (författare)
  • Jakobsen, Janus ChristianCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Cardiology, Holbæk Hospital, Holbæk, Denmark. (författare)
  • Winkel, PerCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (författare)
  • Gluud, ChristianCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (författare)
  • Ärnlöv, Johan,1970-Karolinska Institutet,Högskolan Dalarna,Medicinsk vetenskap,Karolinska institutet(Swepub:du)jan (författare)
  • Department of Emergency Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden.Kardiovaskulär epidemiologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Atherosclerosis: Elsevier BV284, s. 202-2080021-91501879-1484

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy